Medicenna in the spotlight (part VIII)

Update on MDNA11 program

Before we pick up the trail on our last Medicenna update, it is worth noting a story that is developing that could impact the whole bio industry, which is a healthcare bill making noise in Washington. Congress and the White House are planning to have a vote on a bill that would allow Medicare to be able to use its purchasing power to negotiate lower dru…